Lv3
208 积分 2025-05-25 加入
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
10天前
已完结
Corrigendum to “Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group”
20天前
已关闭
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
20天前
已完结
Diagnosis of digestive system tumours
20天前
已完结
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
20天前
已完结
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
1个月前
已完结
SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials
1个月前
已完结
SPIRIT 2025 statement: updated guideline for protocols of randomised trials
1个月前
已完结
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
3个月前
已完结
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
3个月前
已完结
皖公网安备34019202002308
